Please select the option that best describes you:

Would you offer local therapy with either SBRT or Y-90 in a patient with metastatic ER+ HER2 low breast cancer with two oligometastatic liver lesions currently on AI + CDK4/6 inhibitor?  

Answer from: Medical Oncologist at Community Practice
Medical Oncologist at Indiana University School of Medicine
No. Much shorter long answer...we've studied loca...
Sign in or Register to read more